@primalpoly https://t.co/VkehyhUmAN they do work to preventively but I guess it has to be weighted against the possible side effects https://t.co/jOI1U0qTUD
@M1aSpringfield @jjcarsIV @nickmmark Both are associated with reduced mortality. https://t.co/dTYuJKjcdj
@galaxysplain @Drlipid I found this, but these are not low risk by my standards. "Low cardiovascular risk was defined as an observed 10-year risk of less than 20% for cardiovascular-related death or nonfatal myocardial infarction." This is a very high thr
@DrJColeridge @Libertarian61 @holmanm Interesting characterization of “no benefit” https://t.co/X5ZQlU8G0Q
First, tool counts only fatal MI and stroke. Nonfatal MI and stroke are green smileys I guess?? That’s a totally wrong representation of risk. Good data out there showing statins prevent nonfatal MI and stroke even in low risk 1ary prev /2 https://t.co/yXh
Again at face value this one also looks good. Meta-analysis of statin use studies for people with low CVD risk, with relative risks under 1.0. https://t.co/zpQDvMgKBj I’d quibble with their def. of low risk as <20% estimated. But they also analyzed fo
@DrMcInnisDIT @drjohnm @AndrewFoy82 my understanding of the data is that statins are efficacious regardless of baseline risk: https://t.co/81JRLYpozA https://t.co/qihnwf9996 https://t.co/bmJfLY4M9m https://t.co/PNZYdXL3il
RT @aheadmap: 低リスク患者におけるスタチンのNNTはその相対危険のインパクトからするとかなり高いのです。 CMAJ. 2011 Nov 8; 183(16): e1189–e1202.https://t.co/CPOwb6iu0X
@jonathanrockoff @WSJhealth @ronwinslow Research showing statin benefit to even low risk patients known for years http://t.co/a5bwYozOsk
"Physicians and patients should consider whether it is worth taking a medication for 10 years to hopefully be the... http://t.co/Zv2xGLHEKB
心血管リスクの低い患者に対するスタチンの一次予防効果。死亡・心血管疾患罹患を減らす。 http://t.co/lunhLHCr
低リスクの一次予防としてのスタチンの効果。メタ分析。日本の研究も加えられている。COIも少し気になるが、総死亡率も減少するとのこと。メタリグレッションや感度分析などの付録が多く、表なのでくみ取りにくいなぁ。 http://t.co/UmDBKAkA
RT @llozanom: Para la polémica: estatinas y prevención primaria: un metanalisis: - http://t.co/VVuG5hHY
RT @llozanom: Para la polémica: estatinas y prevención primaria: un metanalisis: - http://t.co/VVuG5hHY
"@CharlieNeck: Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis http://t.co/xpKcSAd1"
RT @CharlieNeck: Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis http://t.co/mz643QdP
Statins prevent death even in people @ low risk. http://t.co/0mYYE1eq The #Pillbook 14 p 1048
Statins prevent death even in people @ low risk. http://t.co/LPdGO9Jj The #Pillbook 14 p 1048
Efficacy of statins for primary prevention in people at low cardiovascular risk http://t.co/jifk9ZgH
Missed It? Efficacy of #Statins for primary prevention in people at low cardiovascular risk. #CMAJ: http://t.co/3jfx0Uwk #CV
RT @SIETES7: CMAJ: Estatinas en prev. primaria en pacientes de bajo riesgo cardiovascular. Metanálisis http://t.co/8x93poDH No se, no se...
RT @SIETES7: CMAJ: Estatinas en prev. primaria en pacientes de bajo riesgo cardiovascular. Metanálisis http://t.co/8x93poDH No se, no se...
CMAJ: Estatinas en prev. primaria en pacientes de bajo riesgo cardiovascular. Metanálisis http://t.co/8x93poDH No se, no se...
(CMAJ) Eficacia de las estatinas en personas de bajo riesgo en prev 1ª http://t.co/fX3vfhUX OJO a los resultados. Y OJO al 1º comentario